Baird raised the firm’s price target on DexCom (DXCM) to $115 from $104 and keeps an Outperform rating on the shares. The firm said the second half of 2025 will see catalysts as it growth tailwinds continue to build.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXCM: